Product NewsTopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
Product NewsPowderMed’s Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients
Product NewsTopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsTopoTarget initiates pivotal Phase II trial with Savicol™ for FAP (an inherited pre-disposition to develop colon cancer)
Product NewsARDANA’S NOVEL TESTOSTERONE CREAM REMAINS ON TRACK FOR Q4 2007 LAUNCH FOLLOWING PRE-IND MEETING WITH US FDA.
Product NewsGemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis
Product NewsSYMPHOGEN’S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
